What is Clinical Research?
Clinical research is a process to study the safety and effectiveness of new drugs or other treatments. Clinical research may be carried out in a number of phases, where each phase has its own goal.

Phase I clinical trials are done on 20-80 people to see how safe the drug(s) are, how they work with other medicines, and what doses can be tolerated. Phase II clinical trials are done on 100-300 people to see if the drug works better than current therapies for specific diseases or conditions. Phase III clinical trials are done on 1,000-3,000 people to compare one treatment

Importance of Clinical Research
Clinical research is the process of gathering data on the safety and efficacy of new drugs. It can be done in three ways: randomized controlled trials, observational studies, and case-control studies.

Clinical research is crucial to the pharmaceutical industry. It allows them to get valuable insights into how their drugs are working on patients, what doses are best for certain types of patients, and how they can improve their products in order to help more people. Clinical research also helps doctors make better decisions when prescribing medications for their patients.

It is important that clinical research be accurate and ethical so that we can gain a true understanding of the benefits and risks of a drug before it is approved for use in the general population.

How Clinical Research Courses helps to start career in Clinical Research
Clinical research courses are the best way to learn about clinical trials and how they work.
In this section, we will explore the process of clinical research from start to finish. We will also discuss what a clinical researcher does and how they can help with a patient’s treatment.

Pharmacovigilance courses are a great way to learn more about this field and how it can help patients in need.

Phases of Clinical Trials
Clinical trials are used to assess the safety and effectiveness of drugs, devices, or other interventions. They are often sponsored by pharmaceutical companies and research institutions. Clinical trials can be divided into four phases.

Phase I: The drug is given to a small group of people (20-80) for the first time, usually healthy people who don't have the disease that the drug is intended to treat. The purpose is to evaluate its safety, identify side effects, determine a safe dosage range and best dose schedule for future studies, and identify potential serious risks that need more study.

Phase II: This phase is designed to test whether or not the drug works against the disease it's intended for (proof of concept). A larger group of people with the disease will be given either an inactive substance.

Phase III: clinical trials are typically large, expensive, and lengthy. They are designed to provide the final data for the efficacy and safety of the drug.

Phase-4 clinical trials on the other hand are not required by law to be as large or costly as phase-3 trials.

Phase 3 clinical trial is usually initiated when a pharmaceutical company has gathered enough information through prior phases that it is confident about its product’s safety and efficacy in treating disease symptoms. A phase 3 trial typically involves hundreds or thousands. Clinical Data Management is also important.